Longbio Pharma
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-31
RECRUITING1
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| LP-003 NCT07291284 |
P3 | Active, not recruiting | Seasonal Allergic Rhinitis | 546 | 2026-03-31 |
| LP-005 Injection NCT07212426 |
P2 | Active, not recruiting | PNH - Paroxysmal Nocturnal Hemoglobinuria | 30 | 2026-05-06 |
| LP-003 Dose 1 (Single) NCT07148557 |
P1/2 | Active, not recruiting | Allergic Diseases | 6 | 2026-05-31 |
| LP-003 Injection NCT07313917 |
P2 | Not yet recruiting | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | 150 | 2027-02-28 |
| LP-003 Injection NCT07342803 |
P2 | Recruiting | Allergic Asthma | 200 | 2027-12-28 |
| LP-005 Injection NCT07266155 |
P2 | Not yet recruiting | Paroxysmal Nocturnal Hemoglobinuria | 30 | 2027-12-30 |
| LP-005 Injection NCT07363265 |
P2 | Not yet recruiting | Complement-mediated Renal Diseases | 46 | 2028-08-02 |